SNAPSHOT
Created at: 2019-01-04 09:03
AOP ID and Title:
Status
| Author status | OECD status | OECD project | SAAOP status |
|---|---|---|---|
| Under development: Not open for comment. Do not cite | 1.29 | Under Development |
Abstract
This putative adverse outcome pathway (AOP) outlines potential key events leading to a tumor outcome in standard carcinogenicity models. This information is based largely on modes of action described previously in cited literature sources and is intended as a resource template for AOP development and data organization. Presentation in this Wiki does not indicate EPA acceptance of a particular pathway for a given reference agent, only that the information has been proposed in some manner. In addition, this putative AOP relates to the model species indicated and does not directly address issues of human relevance.
Summary of the AOP
Events
Molecular Initiating Events (MIE), Key Events (KE), Adverse Outcomes (AO)
| Sequence | Type | Event ID | Title | Short name |
|---|---|---|---|---|
| 1 | MIE | 1028 | Activation of specific nuclear receptors, PPAR-gamma activation | Activation of specific nuclear receptors, PPAR-gamma activation |
| 2 | KE | 1029 | Increased, adipogenesis | Increased, adipogenesis |
| 3 | KE | 1032 | Increased, secretion of local growth factors | Increased, secretion of local growth factors |
| 4 | KE | 1033 | Increased, proliferation of mesenchymal cells | Increased, proliferation of mesenchymal cells |
| 5 | KE | 1034 | Increased, IGF-1 (mouse) | Increased, IGF-1 (mouse) |
| 6 | KE | 1035 | Increased, Firbrosarcoma | Increased, Firbrosarcoma |
| 7 | KE | 1036 | Increased, liposarcoma | Increased, liposarcoma |
| 8 | KE | 1037 | Increased, hemagiosarcoma | Increased, hemagiosarcoma |
Key Event Relationships
| Upstream Event | Relationship Type | Downstream Event | Evidence | Quantitative Understanding |
|---|---|---|---|---|
| Increased, adipogenesis | adjacent | Increased, secretion of local growth factors | High | |
| Increased, secretion of local growth factors | adjacent | Increased, proliferation of mesenchymal cells | High | |
| Increased, secretion of local growth factors | adjacent | Increased, IGF-1 (mouse) | High | |
| Increased, proliferation of mesenchymal cells | adjacent | Increased, Firbrosarcoma | High | |
| Increased, proliferation of mesenchymal cells | adjacent | Increased, liposarcoma | High | |
| Increased, proliferation of mesenchymal cells | adjacent | Increased, hemagiosarcoma | High | |
| Activation of specific nuclear receptors, PPAR-gamma activation | non-adjacent | Increased, adipogenesis | High | |
| Activation of specific nuclear receptors, PPAR-gamma activation | non-adjacent | Increased, secretion of local growth factors | Moderate |
Stressors
| Name | Evidence |
|---|---|
| Troglitazone |
Overall Assessment of the AOP
Domain of Applicability
Taxonomic ApplicabilityReferences
1. Cohen, S. M. (2005). Effects of PPARgamma and combined agonists on the urinary tract of rats and other species. Toxicological sciences : an official journal of the Society of Toxicology 87(2), 322-7, 10.1093/toxsci/kfi266.
2. Hardisty, J. F., Elwell, M. R., Ernst, H., Greaves, P., Kolenda-Roberts, H., Malarkey, D. E., Mann, P. C., and Tellier, P. A. (2007). Histopathology of hemangiosarcomas in mice and hamsters and liposarcomas/fibrosarcomas in rats associated with PPAR agonists. Toxicologic pathology 35(7), 928-41, 10.1080/01926230701748156.
3. Kakiuchi-Kiyota, S., Arnold, L. L., Yokohira, M., Koza-Taylor, P., Suzuki, S., Varney, M., Pennington, K. L., and Cohen, S. M. (2011a). Evaluation of direct and indirect effects of the PPARgamma agonist troglitazone on mouse endothelial cell proliferation. Toxicologic pathology 39(7), 1032-45, 10.1177/0192623311422080.
4. Kakiuchi-Kiyota, S., Arnold, L. L., Yokohira, M., Suzuki, S., Pennington, K. L., and Cohen, S. M. (2011b). Evaluation of PPARgamma agonists on rodent endothelial cell proliferation. Toxicology 287(1-3), 91-8, 10.1016/j.tox.2011.05.019.
5. Long, G. G., Reynolds, V. L., Dochterman, L. W., and Ryan, T. E. (2009). Neoplastic and non-neoplastic changes in F-344 rats treated with Naveglitazar, a gamma-dominant PPAR alpha/gamma agonist. Toxicologic pathology 37(6), 741-53, 10.1177/0192623309343775.
Appendix 1
List of MIEs in this AOP
Event: 1028: Activation of specific nuclear receptors, PPAR-gamma activation
Short Name: Activation of specific nuclear receptors, PPAR-gamma activation
Key Event Component
| Process | Object | Action |
|---|---|---|
| peroxisome proliferator activated receptor signaling pathway | peroxisome proliferator-activated receptor gamma | decreased |
AOPs Including This Key Event
| AOP ID and Name | Event Type |
|---|---|
| Aop:163 - PPARgamma activation leading to sarcomas in rats, mice, and hamsters | MolecularInitiatingEvent |
| Aop:72 - Epigenetic modification of PPARG leading to adipogenesis | KeyEvent |
Stressors
| Name |
|---|
| Tetrabromobisphenol A |
Biological Context
| Level of Biological Organization |
|---|
| Molecular |
Cell term
| Cell term |
|---|
| hepatocyte |
Evidence for Perturbation by Stressor
Tetrabromobisphenol A
TBBPA binds to PPARγ in vitro, with a Kd of 0.78 µM and in vivo in zebrafish, with a LOEL of 100 nM (Fang et al., 2015; Riu et al., 2011; Riu et al., 2014). Mild activation has also been reported in vitro in several research papers and in ToxCast assays as well, with effective doses ranging from 0.3 to 10 µM (Riu et al., 2011; Riu et al., 2014; Suzuki et al., 2013; ToxCastTM Data; Watt and Schlezinger, 2015).
List of Key Events in the AOP
Event: 1029: Increased, adipogenesis
Short Name: Increased, adipogenesis
Key Event Component
| Process | Object | Action |
|---|---|---|
| fat cell differentiation | increased |
AOPs Including This Key Event
| AOP ID and Name | Event Type |
|---|---|
| Aop:163 - PPARgamma activation leading to sarcomas in rats, mice, and hamsters | KeyEvent |
Biological Context
| Level of Biological Organization |
|---|
| Cellular |
Cell term
| Cell term |
|---|
| eukaryotic cell |
Event: 1032: Increased, secretion of local growth factors
Short Name: Increased, secretion of local growth factors
Key Event Component
| Process | Object | Action |
|---|---|---|
| secretion | eukaryotic protein | increased |
AOPs Including This Key Event
Biological Context
| Level of Biological Organization |
|---|
| Cellular |
Cell term
| Cell term |
|---|
| eukaryotic cell |
Event: 1033: Increased, proliferation of mesenchymal cells
Short Name: Increased, proliferation of mesenchymal cells
Key Event Component
| Process | Object | Action |
|---|---|---|
| mesenchymal cell proliferation | mesenchymal cell | increased |
AOPs Including This Key Event
| AOP ID and Name | Event Type |
|---|---|
| Aop:163 - PPARgamma activation leading to sarcomas in rats, mice, and hamsters | KeyEvent |
Biological Context
| Level of Biological Organization |
|---|
| Cellular |
Cell term
| Cell term |
|---|
| mesenchymal cell |
Event: 1034: Increased, IGF-1 (mouse)
Short Name: Increased, IGF-1 (mouse)
Key Event Component
| Process | Object | Action |
|---|---|---|
| gene expression | IGF-like family receptor 1 (mouse) | increased |
AOPs Including This Key Event
| AOP ID and Name | Event Type |
|---|---|
| Aop:163 - PPARgamma activation leading to sarcomas in rats, mice, and hamsters | KeyEvent |
Biological Context
| Level of Biological Organization |
|---|
| Cellular |
Cell term
| Cell term |
|---|
| eukaryotic cell |
Event: 1035: Increased, Firbrosarcoma
Short Name: Increased, Firbrosarcoma
Key Event Component
| Process | Object | Action |
|---|---|---|
| Fibrosarcoma | increased |
AOPs Including This Key Event
| AOP ID and Name | Event Type |
|---|---|
| Aop:163 - PPARgamma activation leading to sarcomas in rats, mice, and hamsters | KeyEvent |
Biological Context
| Level of Biological Organization |
|---|
| Tissue |
Organ term
| Organ term |
|---|
| fibrous connective tissue |
Event: 1036: Increased, liposarcoma
Short Name: Increased, liposarcoma
Key Event Component
| Process | Object | Action |
|---|---|---|
| liposarcoma | increased |
AOPs Including This Key Event
| AOP ID and Name | Event Type |
|---|---|
| Aop:163 - PPARgamma activation leading to sarcomas in rats, mice, and hamsters | KeyEvent |
Biological Context
| Level of Biological Organization |
|---|
| Tissue |
Organ term
| Organ term |
|---|
| adipose tissue |
Event: 1037: Increased, hemagiosarcoma
Short Name: Increased, hemagiosarcoma
Key Event Component
| Process | Object | Action |
|---|---|---|
| hemangiosarcoma | increased |
AOPs Including This Key Event
| AOP ID and Name | Event Type |
|---|---|
| Aop:163 - PPARgamma activation leading to sarcomas in rats, mice, and hamsters | KeyEvent |
Biological Context
| Level of Biological Organization |
|---|
| Tissue |
Organ term
| Organ term |
|---|
| blood vessel endothelium |
Appendix 2
List of Key Event Relationships in the AOP
List of Adjacent Key Event Relationships
Relationship: 1073: Increased, adipogenesis leads to Increased, secretion of local growth factors
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding |
|---|---|---|---|
| PPARgamma activation leading to sarcomas in rats, mice, and hamsters | adjacent | High |
Relationship: 1074: Increased, secretion of local growth factors leads to Increased, proliferation of mesenchymal cells
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding |
|---|---|---|---|
| PPARgamma activation leading to sarcomas in rats, mice, and hamsters | adjacent | High |
Relationship: 1075: Increased, secretion of local growth factors leads to Increased, IGF-1 (mouse)
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding |
|---|---|---|---|
| PPARgamma activation leading to sarcomas in rats, mice, and hamsters | adjacent | High |
Relationship: 1076: Increased, proliferation of mesenchymal cells leads to Increased, Firbrosarcoma
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding |
|---|---|---|---|
| PPARgamma activation leading to sarcomas in rats, mice, and hamsters | adjacent | High |
Relationship: 1077: Increased, proliferation of mesenchymal cells leads to Increased, liposarcoma
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding |
|---|---|---|---|
| PPARgamma activation leading to sarcomas in rats, mice, and hamsters | adjacent | High |
Relationship: 1078: Increased, proliferation of mesenchymal cells leads to Increased, hemagiosarcoma
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding |
|---|---|---|---|
| PPARgamma activation leading to sarcomas in rats, mice, and hamsters | adjacent | High |
List of Non Adjacent Key Event Relationships
Relationship: 1071: Activation of specific nuclear receptors, PPAR-gamma activation leads to Increased, adipogenesis
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding |
|---|---|---|---|
| PPARgamma activation leading to sarcomas in rats, mice, and hamsters | non-adjacent | High |
Relationship: 1072: Activation of specific nuclear receptors, PPAR-gamma activation leads to Increased, secretion of local growth factors
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding |
|---|---|---|---|
| PPARgamma activation leading to sarcomas in rats, mice, and hamsters | non-adjacent | Moderate |